Researchers assigned intracranial arterial stenosis patients to either aggressive medical management alone or aggressive medical management with PTAS and then analyzed the outcomes after 30 days.
They found that 14.7 percent of patients in the PTAS group had a stroke or died after 30 days compared to 5.8 percent of the medical management group.
The authors suggest medical management alone is superior to PTAS for patients with intracranial arterial stenosis because the risk of stroke was greater than expected in the PTAS group and lower than expected in the medical management group.
Related Articles on Hospital Cardiology:
UCSF Medical Center’s Heart Program Helped Lower Readmissions by 30%
Cardiology Consultants Joins Florida’s Baptist Health Care
Indiana’s Fayette Regional Opts for St. Vincent Over Reid Hospital for Cardiac Care
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
